- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02525939
Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS (dal-GenE)
A Phase III, Double-blind, Randomized Placebo-controlled Study to Evaluate the Effects of Dalcetrapib on Cardiovascular (CV) Risk in a Genetically Defined Population With a Recent Acute Coronary Syndrome (ACS): The Dal-GenE Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is an event driven study to reach statistical power given all other assumptions. Subjects will visit the clinic 1 month after randomization and at regular intervals thereafter. Additionally, for any subject prematurely discontinuing study medication, assessments will be conducted every 6 months for the collection of study endpoints.
Those who are likely to qualify will undergo Genotype Assay Testing to evaluate genetic determination or the presence of the AA genotype. The test is investigational and test procedures are Roche Molecular Diagnostics protocol ADCY9-COB-389.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Bahía Blanca, Argentina
- Research Site
-
Ciudad Autonoma de Buenos Aires, Argentina
- Research Site
-
Cordoba, Argentina
- Research Site
-
Coronel Suarez, Argentina
- Research Site
-
Corrientes, Argentina
- Research Site
-
Esperanza, Argentina
- Research Site
-
Junin, Argentina
- Research Site
-
La Plata, Argentina
- Research Site
-
Mar del Plata, Argentina
- Research Site
-
Mendoza, Argentina
- Research Site
-
Moron, Argentina
- Research Site
-
Quilmes, Argentina
- Research Site
-
Rosario, Argentina
- Research Site
-
San Juan, Argentina
- Research Site
-
San Luis, Argentina
- Research Site
-
San Martin, Argentina
- Research Site
-
San Miguel de Tucuman, Argentina
- Research Site
-
San Nicolas, Argentina
- Research Site
-
Santa Fe, Argentina
- Research Site
-
Santa Rosa, Argentina
- Research Site
-
Tucuman, Argentina
- Research Site
-
Venado Tuerto, Argentina
- Research Site
-
Vicente Lopez, Argentina
- Research Site
-
Villa Allende, Argentina
- Research Site
-
Villa Maria, Argentina
- Research Site
-
-
-
-
New South Wales
-
Bruce, New South Wales, Australia
- Research Site
-
Gosford, New South Wales, Australia
- Research Site
-
Liverpool, New South Wales, Australia
- Research Site
-
Saint Leonards, New South Wales, Australia
- Research Site
-
-
Queensland
-
Cairns, Queensland, Australia
- Research Site
-
Chermside, Queensland, Australia
- Research Site
-
Douglas, Queensland, Australia
- Research Site
-
Herston, Queensland, Australia
- Research Site
-
Milton, Queensland, Australia
- Research Site
-
Redcliffe, Queensland, Australia
- Research Site
-
Woolloongabba, Queensland, Australia
- Research Site
-
-
South Australia
-
Bedford Park, South Australia, Australia
- Research Site
-
Elizabeth Vale, South Australia, Australia
- Research Site
-
Woodville South, South Australia, Australia
- Research Site
-
-
Tasmania
-
Hobart, Tasmania, Australia
- Research Site
-
-
Victoria
-
Epping, Victoria, Australia
- Research Site
-
Geelong, Victoria, Australia
- Research Site
-
Melbourne, Victoria, Australia
- Research Site
-
-
Western Australia
-
Joondalup, Western Australia, Australia
- Research Site
-
Murdoch, Western Australia, Australia
- Research Site
-
Nedlands, Western Australia, Australia
- Research Site
-
Perth, Western Australia, Australia
- Research Site
-
-
-
-
-
Braunau Am Inn, Austria
- Research Site
-
Feldkirch, Austria
- Research Site
-
Krems, Austria
- Research Site
-
Linz, Austria
- Research Site
-
Vienna, Austria
- Research Site
-
Wien, Austria
- Research Site
-
Wiener Neustadt, Austria
- Research Site
-
-
-
-
-
Aalst, Belgium
- Research Site
-
Bonheiden, Belgium
- Research Site
-
Brussels, Belgium
- Research Site
-
Genk, Belgium
- Research Site
-
Liege, Belgium
- Research Site
-
Maaseik, Belgium
- Research Site
-
Mechelen, Belgium
- Research Site
-
Ottignies, Belgium
- Research Site
-
Sint-Niklaas, Belgium
- Research Site
-
-
-
-
-
Belo Horizonte, Brazil
- Research Site
-
Blumenau, Brazil
- Research Site
-
Brasilia, Brazil
- Research Site
-
Campina Grande do Sul, Brazil
- Research Site
-
Campinas, Brazil
- Research Site
-
Campo Grande, Brazil
- Research Site
-
Curitiba, Brazil
- Research Site
-
Fortaleza, Brazil
- Research Site
-
Goiania, Brazil
- Research Site
-
Marilia, Brazil
- Research Site
-
Maringa, Brazil
- Research Site
-
Natal, Brazil
- Research Site
-
Porto Alegre, Brazil
- Research Site
-
Recife, Brazil
- Research Site
-
Ribeirao Preto, Brazil
- Research Site
-
Salvador, Brazil
- Research Site
-
Santo André, Brazil
- Research Site
-
Sao Jose do Rio Preto, Brazil
- Research Site
-
Sao Paulo, Brazil
- Research Site
-
Uberlandia, Brazil
- Research Site
-
Vitoria, Brazil
- Research Site
-
-
-
-
-
Blagoevgrad, Bulgaria
- Research Site
-
Dimitrovgrad, Bulgaria
- Research Site
-
Haskovo, Bulgaria
- Research Site
-
Pazardzhik, Bulgaria
- Research Site
-
Pernik, Bulgaria
- Research Site
-
Pleven, Bulgaria
- Research Site
-
Plovdiv, Bulgaria
- Research Site
-
Sandanski, Bulgaria
- Research Site
-
Sofia, Bulgaria
- Research Site
-
-
-
-
-
Quebec, Canada
- Research Site
-
Québec, Canada
- Research Site
-
-
Alberta
-
Calgary, Alberta, Canada
- Research Site
-
Edmonton, Alberta, Canada
- Research Site
-
-
British Columbia
-
Vancouver, British Columbia, Canada
- Research Site
-
Victoria, British Columbia, Canada
- Research Site
-
-
Manitoba
-
Winnipeg, Manitoba, Canada
- Research Site
-
-
New Brunswick
-
Moncton, New Brunswick, Canada
- Research Site
-
Saint John, New Brunswick, Canada
- Research Site
-
-
Newfoundland and Labrador
-
St. John's, Newfoundland and Labrador, Canada
- Research Site
-
-
Nova Scotia
-
Bridgewater, Nova Scotia, Canada
- Research Site
-
-
Ontario
-
Burlington, Ontario, Canada
- Research Site
-
Cambridge, Ontario, Canada
- Research Site
-
Hamilton, Ontario, Canada
- Research Site
-
London, Ontario, Canada
- Research Site
-
Newmarket, Ontario, Canada
- Research Site
-
Ottawa, Ontario, Canada
- Research Site
-
Peterborough, Ontario, Canada
- Research Site
-
Scarborough, Ontario, Canada
- Research Site
-
Sudbury, Ontario, Canada
- Research Site
-
Thunder Bay, Ontario, Canada
- Research Site
-
Toronto, Ontario, Canada
- Research Site
-
-
Quebec
-
Chicoutimi, Quebec, Canada
- Research Site
-
Granby, Quebec, Canada
- Research Site
-
Laval, Quebec, Canada
- Research Site
-
Levis, Quebec, Canada
- Research Site
-
Longueuil, Quebec, Canada
- Research Site
-
Montreal, Quebec, Canada, H1T 1C8
- Institut de Cardiologie de Montréal
-
Montreal, Quebec, Canada
- Research Site
-
Sherbrooke, Quebec, Canada
- Research Site
-
St-Charles-Borromee, Quebec, Canada
- Research Site
-
St-Jean-sur-Richelieu, Quebec, Canada
- Research Site
-
St-Jerome, Quebec, Canada
- Research Site
-
St. George, Quebec, Canada
- Research Site
-
Terrebonne, Quebec, Canada
- Research Site
-
Thetford Mines, Quebec, Canada
- Research Site
-
Trois-Rivieres, Quebec, Canada
- Research Site
-
-
-
-
-
Santiago, Chile
- Research Site
-
Temuco, Chile
- Research Site
-
Vina del Mar, Chile
- Research Site
-
-
-
-
-
Bilina, Czechia
- Research Site
-
Brno, Czechia
- Research Site
-
Hradec Kralove, Czechia
- Research Site
-
Jihlava, Czechia
- Research Site
-
Kladno, Czechia
- Research Site
-
Kromeriz, Czechia
- Research Site
-
Liberec, Czechia
- Research Site
-
Nachod, Czechia
- Research Site
-
Pisek, Czechia
- Research Site
-
Plzen, Czechia
- Research Site
-
Prague, Czechia
- Research Site
-
Prague 2, Czechia
- Research Site
-
Prague 5, Czechia
- Research Site
-
Prague 6, Czechia
- Research Site
-
Slany, Czechia
- Research Site
-
Trutnov, Czechia
- Research Site
-
Zlin, Czechia
- Research Site
-
-
-
-
-
Aalborg, Denmark
- Research Site
-
Frederiksberg, Denmark
- Research Site
-
Glostrup, Denmark
- Research Site
-
Hellerup, Denmark
- Research Site
-
Herning, Denmark
- Research Site
-
Hillerod, Denmark
- Research Site
-
Kobenhavn, Denmark
- Research Site
-
Naestved, Denmark
- Research Site
-
Silkeborg, Denmark
- Research Site
-
-
-
-
-
Jyvaskyla, Finland
- Research Site
-
Oulu, Finland
- Research Site
-
Pori, Finland
- Research Site
-
Turku, Finland
- Research Site
-
-
-
-
-
Besancon, France
- Research Site
-
Bron, France
- Research Site
-
Clermont-Ferrand, France
- Research Site
-
Corbeil-Essonnes, France
- Research Site
-
Dijon, France
- Research Site
-
Limoges, France
- Research Site
-
Lyon, France
- Research Site
-
Montpellier, France
- Research Site
-
Paris, France
- Research Site
-
Pessac, France
- Research Site
-
Poitiers, France
- Research Site
-
Toulouse, France
- Research Site
-
Tourcoing, France
- Research Site
-
Valenciennes, France
- Research Site
-
-
-
-
-
Aachen, Germany
- Research Site
-
Berlin, Germany
- Research Site
-
Bochum, Germany
- Research Site
-
Bremen, Germany
- Research Site
-
Chemnitz, Germany
- Research Site
-
Coburg, Germany
- Research Site
-
Dresden, Germany
- Research Site
-
Erfurt, Germany
- Research Site
-
Fuerth, Germany
- Research Site
-
Heidelberg, Germany
- Research Site
-
Leipzig, Germany
- Research Site
-
Mainz, Germany
- Research Site
-
Monchengladbach, Germany
- Research Site
-
Munich, Germany
- Research Site
-
-
-
-
-
Baja, Hungary
- Research Site
-
Balatonfured, Hungary
- Research Site
-
Budapest, Hungary
- Research Site
-
Eger, Hungary
- Research Site
-
Gyula, Hungary
- Research Site
-
Hatvan, Hungary
- Research Site
-
Kecskemet, Hungary
- Research Site
-
Miskolc, Hungary
- Research Site
-
Nyiregyhaza, Hungary
- Research Site
-
Pecs, Hungary
- Research Site
-
Szekesfehervar, Hungary
- Research Site
-
Szombathely, Hungary
- Research Site
-
Zalaegerszeg, Hungary
- Research Site
-
-
-
-
-
Afula, Israel
- Research Site
-
Ashkelon, Israel
- Research Site
-
Beer Sheva, Israel
- Research Site
-
Bnei Brak, Israel
- Research Site
-
Haifa, Israel
- Research Site
-
Holon, Israel
- Research Site
-
Jerusalem, Israel
- Research Site
-
Kfar Saba, Israel
- Research Site
-
Nahariya, Israel
- Research Site
-
Nazareth, Israel
- Research Site
-
Petach-Tikva, Israel
- Research Site
-
Poriyya 'Illit, Israel
- Research Site
-
Rehovot, Israel
- Research Site
-
Safed, Israel
- Research Site
-
Tel Aviv, Israel
- Research Site
-
Tel Hashomer, Israel
- Research Site
-
Zerifin, Israel
- Research Site
-
-
-
-
-
Ancona, Italy
- Research Site
-
Ascoli Piceno, Italy
- Research Site
-
Cagliari, Italy
- Research Site
-
Casarano, Italy
- Research Site
-
Cortona, Italy
- Research Site
-
Empoli, Italy
- Research Site
-
Firenze, Italy
- Research Site
-
Foggia, Italy
- Research Site
-
Giugliano in Campania, Italy
- Research Site
-
Gubbio, Italy
- Research Site
-
Milano, Italy
- Research Site
-
Napoli, Italy
- Research Site
-
Novara, Italy
- Research Site
-
Roma, Italy
- Research Site
-
Rozzano, Italy
- Research Site
-
Sanremo, Italy
- Research Site
-
Saronno, Italy
- Research Site
-
Scorrano, Italy
- Research Site
-
Seriate, Italy
- Research Site
-
Torino, Italy
- Research Site
-
Treviglio, Italy
- Research Site
-
-
-
-
-
's-Hertogenbosch, Netherlands
- Research Site
-
Amsterdam, Netherlands
- Research Site
-
Arnhem, Netherlands
- Research Site
-
Capelle Aan Den IJssel, Netherlands
- Research Site
-
Den Haag, Netherlands
- Research Site
-
Deventer, Netherlands
- Research Site
-
Doetinchem, Netherlands
- Research Site
-
Ede, Netherlands
- Research Site
-
Goes, Netherlands
- Research Site
-
Gouda, Netherlands
- Research Site
-
Hoogeveen, Netherlands
- Research Site
-
Hoorn, Netherlands
- Research Site
-
Leeuwarden, Netherlands
- Research Site
-
Leiden, Netherlands
- Research Site
-
Rotterdam, Netherlands
- Research Site
-
Schiedam, Netherlands
- Research Site
-
Sneek, Netherlands
- Research Site
-
Tiel, Netherlands
- Research Site
-
Tilburg, Netherlands
- Research Site
-
Uden, Netherlands
- Research Site
-
Veldhoven, Netherlands
- Research Site
-
Venlo, Netherlands
- Research Site
-
Zaandam, Netherlands
- Research Site
-
Zutphen, Netherlands
- Research Site
-
-
-
-
-
Christchurch, New Zealand
- Research Site
-
Dunedin, New Zealand
- Research Site
-
Grafton, New Zealand
- Research Site
-
Hamilton, New Zealand
- Research Site
-
Hastings, New Zealand
- Research Site
-
Lower Hutt, New Zealand
- Research Site
-
Nelson, New Zealand
- Research Site
-
New Plymouth, New Zealand
- Research Site
-
Rotorua, New Zealand
- Research Site
-
Takapuna, New Zealand
- Research Site
-
Wellington, New Zealand
- Research Site
-
-
-
-
-
Bydgoszcz, Poland
- Research Site
-
Elblag, Poland
- Research Site
-
Gdynia, Poland
- Research Site
-
Kielce, Poland
- Research Site
-
Krakow, Poland
- Research Site
-
Lodz, Poland
- Research Site
-
Mragowo, Poland
- Research Site
-
Olawa, Poland
- Research Site
-
Oswiecim, Poland
- Research Site
-
Plock, Poland
- Research Site
-
Poznan, Poland
- Research Site
-
Ruda Slaska, Poland
- Research Site
-
Rzeszow, Poland
- Research Site
-
Sopot, Poland
- Research Site
-
Sroda Wielkopolska, Poland
- Research Site
-
Szczecin, Poland
- Research Site
-
Torun, Poland
- Research Site
-
Wroclaw, Poland
- Research Site
-
Zabrze, Poland
- Research Site
-
Zamosc, Poland
- Research Site
-
-
-
-
-
Almada, Portugal
- Research Site
-
Braga, Portugal
- Research Site
-
Coimbra, Portugal
- Research Site
-
Faro, Portugal
- Research Site
-
Leiria, Portugal
- Research Site
-
Lisboa, Portugal
- Research Site
-
Senhora da Hora, Portugal
- Research Site
-
Setubal, Portugal
- Research Site
-
-
-
-
-
Bayamon, Puerto Rico
- Research Site
-
Caguas, Puerto Rico
- Research Site
-
Ponce, Puerto Rico
- Research Site
-
-
-
-
-
Arad, Romania
- Research Site
-
Baia Mare, Romania
- Research Site
-
Braila, Romania
- Research Site
-
Bucharest, Romania
- Research Site
-
Buzau, Romania
- Research Site
-
Cluj-Napoca, Romania
- Research Site
-
Craiova, Romania
- Research Site
-
Oradea, Romania
- Research Site
-
Pitesti, Romania
- Research Site
-
Timisoara, Romania
- Research Site
-
-
-
-
-
Arkhangelsk, Russian Federation
- Research Site
-
Barnaul, Russian Federation
- Research Site
-
Ekaterinburg, Russian Federation
- Research Site
-
Irkutsk, Russian Federation
- Research Site
-
Kazan, Russian Federation
- Research Site
-
Kemerovo, Russian Federation
- Research Site
-
Kirovsk, Russian Federation
- Research Site
-
Moscow, Russian Federation
- Research Site
-
Nizhny Novgorod, Russian Federation
- Research Site
-
Novosibirsk, Russian Federation
- Research Site
-
Omsk, Russian Federation
- Research Site
-
Orenburg, Russian Federation
- Research Site
-
Penza, Russian Federation
- Research Site
-
Petrozavodsk, Russian Federation
- Research Site
-
Saint-Petersburg, Russian Federation
- Research Site
-
Saratov, Russian Federation
- Research Site
-
Tomsk, Russian Federation
- Research Site
-
Tula, Russian Federation
- Research Site
-
Tyumen, Russian Federation
- Research Site
-
Yaroslavl, Russian Federation
- Research Site
-
-
-
-
-
Bardejov, Slovakia
- Research Site
-
Bratislava, Slovakia
- Research Site
-
Kosice, Slovakia
- Research Site
-
Lucenec, Slovakia
- Research Site
-
Namestovo, Slovakia
- Research Site
-
Nitra, Slovakia
- Research Site
-
-
-
-
-
Bloemfontein, South Africa
- Research Site
-
Cape Town, South Africa
- Research Site
-
Gatong, South Africa
- Research Site
-
Johannesburg, South Africa
- Research Site
-
Kuils River, South Africa
- Research Site
-
Paarl, South Africa
- Research Site
-
Parow, South Africa
- Research Site
-
Somerset West, South Africa
- Research Site
-
Worcester, South Africa
- Research Site
-
-
-
-
-
A Coruna, Spain
- Research Site
-
Barcelona, Spain
- Research Site
-
Hospitalet del Llobregat, Spain
- Research Site
-
Lleida, Spain
- Research Site
-
Madrid, Spain
- Research Site
-
Malaga, Spain
- Research Site
-
Sabadell, Spain
- Research Site
-
Salamanca, Spain
- Research Site
-
Sant Joan, Spain
- Research Site
-
Santiago de Compostela, Spain
- Research Site
-
Seville, Spain
- Research Site
-
Tarragona, Spain
- Research Site
-
Valencia, Spain
- Research Site
-
Vigo, Spain
- Research Site
-
-
-
-
-
Falun, Sweden
- Research Site
-
Karlshamn, Sweden
- Research Site
-
Koping, Sweden
- Research Site
-
Linkoping, Sweden
- Research Site
-
Malmo, Sweden
- Research Site
-
Orebro, Sweden
- Research Site
-
Umea, Sweden
- Research Site
-
Uppsala, Sweden
- Research Site
-
Vasteras, Sweden
- Research Site
-
-
-
-
-
Geneva, Switzerland
- Research Site
-
Lugano, Switzerland
- Research Site
-
-
-
-
-
Afyonkarahisar, Turkey
- Research Site
-
Ankara, Turkey
- Research Site
-
Istanbul, Turkey
- Research Site
-
Izmir, Turkey
- Research Site
-
Kadikoy, Turkey
- Research Site
-
Kayseri, Turkey
- Research Site
-
Mersin, Turkey
- Research Site
-
Samsun, Turkey
- Research Site
-
Sivas, Turkey
- Research Site
-
-
-
-
-
Dubai, United Arab Emirates
- Research Site
-
Sharjah, United Arab Emirates
- Research Site
-
-
-
-
-
Ayr, United Kingdom
- Research Site
-
Barnet, United Kingdom
- Research Site
-
Basildon, United Kingdom
- Research Site
-
Belfast, United Kingdom
- Research Site
-
Birmingham, United Kingdom
- Research Site
-
Blackpool, United Kingdom
- Research Site
-
Bradford, United Kingdom
- Research Site
-
Bristol, United Kingdom
- Research Site
-
Burton Upon Trent, United Kingdom
- Research Site
-
Chelmsford, United Kingdom
- Research Site
-
Chertsey, United Kingdom
- Research Site
-
Clydebank, United Kingdom
- Research Site
-
Coventry, United Kingdom
- Research Site
-
Craigavon, United Kingdom
- Research Site
-
Dartford, United Kingdom
- Research Site
-
Dudley, United Kingdom
- Research Site
-
Glasgow, United Kingdom
- Research Site
-
Harrow, United Kingdom
- Research Site
-
High Wycombe, United Kingdom
- Research Site
-
Hull, United Kingdom
- Research Site
-
Inverness, United Kingdom
- Research Site
-
Kirkcaldy, United Kingdom
- Research Site
-
Lanark, United Kingdom
- Research Site
-
Leicester, United Kingdom
- Research Site
-
Lincoln, United Kingdom
- Research Site
-
Liverpool, United Kingdom
- Research Site
-
London, United Kingdom
- Research Site
-
Londonderry, United Kingdom
- Research Site
-
Luton, United Kingdom
- Research Site
-
Manchester, United Kingdom
- Research Site
-
Newcastle, United Kingdom
- Research Site
-
Newport, United Kingdom
- Research Site
-
Northampton, United Kingdom
- Research Site
-
Nuneaton, United Kingdom
- Research Site
-
Paisley, United Kingdom
- Research Site
-
Redhill, United Kingdom
- Research Site
-
Romford, United Kingdom
- Research Site
-
Rotherham, United Kingdom
- Research Site
-
Salford, United Kingdom
- Research Site
-
Sheffield, United Kingdom
- Research Site
-
Stevenage, United Kingdom
- Research Site
-
Stockport, United Kingdom
- Research Site
-
Stockton on Tees, United Kingdom
- Research Site
-
Swindon, United Kingdom
- Research Site
-
Taunton, United Kingdom
- Research Site
-
Telford, United Kingdom
- Research Site
-
Truro, United Kingdom
- Research Site
-
West Bromwich, United Kingdom
- Research Site
-
Westcliff on Sea, United Kingdom
- Research Site
-
Wigan, United Kingdom
- Research Site
-
Worcester, United Kingdom
- Research Site
-
Worthing, United Kingdom
- Research Site
-
-
-
-
Alabama
-
Alexander City, Alabama, United States
- Research Site
-
Huntsville, Alabama, United States
- Research Site
-
Mobile, Alabama, United States
- Research Site
-
-
Arizona
-
Cottonwood, Arizona, United States
- Research Site
-
Glendale, Arizona, United States
- Research Site
-
-
Arkansas
-
Jonesboro, Arkansas, United States
- Research Site
-
-
California
-
Huntington Beach, California, United States
- Research Site
-
San Diego, California, United States
- Research Site
-
Torrance, California, United States
- Research Site
-
-
Colorado
-
Denver, Colorado, United States
- Research Site
-
Littleton, Colorado, United States
- Research Site
-
-
Connecticut
-
Danbury, Connecticut, United States
- Research Site
-
Hartford, Connecticut, United States
- Research Site
-
-
District of Columbia
-
Washington, District of Columbia, United States
- Research Site
-
-
Florida
-
Clearwater, Florida, United States
- Research Site
-
Daytona Beach, Florida, United States
- Research Site
-
Fort Lauderdale, Florida, United States
- Research Site
-
Gainesville, Florida, United States
- Research Site
-
Homestead, Florida, United States
- Research Site
-
Hudson, Florida, United States
- Research Site
-
Jacksonville, Florida, United States
- Research Site
-
Largo, Florida, United States
- Research Site
-
Miami, Florida, United States
- Research Site
-
Miramar, Florida, United States
- Research Site
-
Orlando, Florida, United States
- Research Site
-
Pembroke Pines, Florida, United States
- Research Site
-
Pensacola, Florida, United States
- Research Site
-
Port Charlotte, Florida, United States
- Research Site
-
Safety Harbor, Florida, United States
- Research Site
-
Tallahassee, Florida, United States
- Research Site
-
-
Georgia
-
Atlanta, Georgia, United States
- Research Site
-
Columbus, Georgia, United States
- Research Site
-
Covington, Georgia, United States
- Research Site
-
Decatur, Georgia, United States
- Research Site
-
Macon, Georgia, United States
- Research Site
-
-
Illinois
-
Evanston, Illinois, United States
- Research Site
-
Jerseyville, Illinois, United States
- Research Site
-
-
Indiana
-
Fort Wayne, Indiana, United States
- Research Site
-
Newburgh, Indiana, United States
- Research Site
-
-
Iowa
-
West Des Moines, Iowa, United States
- Research Site
-
-
Kansas
-
Wichita, Kansas, United States
- Research Site
-
-
Kentucky
-
Owensboro, Kentucky, United States
- Research Site
-
-
Louisiana
-
Alexandria, Louisiana, United States
- Research Site
-
Covington, Louisiana, United States
- Research Site
-
-
Maine
-
Bangor, Maine, United States
- Research Site
-
Biddeford, Maine, United States
- Research Site
-
Lewiston, Maine, United States
- Research Site
-
-
Maryland
-
Annapolis, Maryland, United States
- Research Site
-
Baltimore, Maryland, United States
- Research Site
-
Bethesda, Maryland, United States
- Research Site
-
Columbia, Maryland, United States
- Research Site
-
Salisbury, Maryland, United States
- Research Site
-
-
Massachusetts
-
Hyannis, Massachusetts, United States
- Research Site
-
-
Michigan
-
Alpena, Michigan, United States
- Research Site
-
Bay City, Michigan, United States
- Research Site
-
Lansing, Michigan, United States
- Research Site
-
Midland, Michigan, United States
- Research Site
-
Mount Clemens, Michigan, United States
- Research Site
-
Muskegon, Michigan, United States
- Research Site
-
Saginaw, Michigan, United States
- Research Site
-
Saint Joseph, Michigan, United States
- Research Site
-
Ypsilanti, Michigan, United States
- Research Site
-
-
Minnesota
-
Coon Rapids, Minnesota, United States
- Research Site
-
Duluth, Minnesota, United States
- Research Site
-
Minneapolis, Minnesota, United States
- Research Site
-
Saint Cloud, Minnesota, United States
- Research Site
-
-
Missouri
-
Saint Louis, Missouri, United States
- Research Site
-
Washington, Missouri, United States
- Research Site
-
-
Montana
-
Missoula, Montana, United States
- Research Site
-
-
Nebraska
-
Omaha, Nebraska, United States
- Research Site
-
-
Nevada
-
Las Vegas, Nevada, United States
- Research Site
-
-
New Jersey
-
Bridgewater, New Jersey, United States
- Research Site
-
Linden, New Jersey, United States
- Research Site
-
Somerset, New Jersey, United States
- Research Site
-
Summit, New Jersey, United States
- Research Site
-
-
New Mexico
-
Albuquerque, New Mexico, United States
- Research Site
-
-
New York
-
Buffalo, New York, United States
- Research Site
-
Johnson City, New York, United States
- Research Site
-
New Windsor, New York, United States
- Research Site
-
New York, New York, United States
- Research Site
-
Poughkeepsie, New York, United States
- Research Site
-
-
North Carolina
-
Asheville, North Carolina, United States
- Research Site
-
Greensboro, North Carolina, United States
- Research Site
-
Pinehurst, North Carolina, United States
- Research Site
-
Rocky Mount, North Carolina, United States
- Research Site
-
Wilmington, North Carolina, United States
- Research Site
-
Winston-Salem, North Carolina, United States
- Research Site
-
-
North Dakota
-
Minot, North Dakota, United States
- Research Site
-
-
Ohio
-
Canton, Ohio, United States
- Research Site
-
Cincinnati, Ohio, United States
- Research Site
-
Columbus, Ohio, United States
- Research Site
-
Springfield, Ohio, United States
- Research Site
-
Toledo, Ohio, United States
- Research Site
-
Zanesville, Ohio, United States
- Research Site
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States
- Research Site
-
-
Pennsylvania
-
Butler, Pennsylvania, United States
- Research Site
-
Chambersburg, Pennsylvania, United States
- Research Site
-
Erie, Pennsylvania, United States
- Research Site
-
Hershey, Pennsylvania, United States
- Research Site
-
Langhorne, Pennsylvania, United States
- Research Site
-
Philadelphia, Pennsylvania, United States
- Research Site
-
Wyomissing, Pennsylvania, United States
- Research Site
-
York, Pennsylvania, United States
- Research Site
-
-
Rhode Island
-
Providence, Rhode Island, United States
- Research Site
-
-
South Carolina
-
Spartanburg, South Carolina, United States
- Research Site
-
-
South Dakota
-
Rapid City, South Dakota, United States
- Research Site
-
-
Tennessee
-
Greeneville, Tennessee, United States
- Research Site
-
Jackson, Tennessee, United States
- Research Site
-
Oak Ridge, Tennessee, United States
- Research Site
-
-
Texas
-
Dallas, Texas, United States
- Research Site
-
Houston, Texas, United States
- Research Site
-
Kingwood, Texas, United States
- Research Site
-
San Antonio, Texas, United States
- Research Site
-
Victoria, Texas, United States
- Research Site
-
Wichita Falls, Texas, United States
- Research Site
-
-
Utah
-
Layton, Utah, United States
- Research Site
-
-
Virginia
-
Charlottesville, Virginia, United States
- Research Site
-
Norfolk, Virginia, United States
- Research Site
-
Virginia Beach, Virginia, United States
- Research Site
-
Winchester, Virginia, United States
- Research Site
-
-
Washington
-
Seattle, Washington, United States
- Research Site
-
-
Wisconsin
-
La Crosse, Wisconsin, United States
- Research Site
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjects with the appropriate genetic background and recently hospitalized for ACS (between 4 and 12 weeks following the index event), will be enrolled in this trial.
- AA genotype at variant gene as determined by Genotype Assay testing, conducted at a designated investigational testing site (ITS)
- Clinically stable, ie, free of ischemic symptoms at rest or with minimal exertion for at least 1 week prior to randomization
- Prior to randomization, subject must have evidence of guidelines-based management of LDL-C, at a minimum to include medical and dietary treatment to a target level of LDL-C <100 mg/dl (<2.6 mmol/L).
Exclusion Criteria:
- Females who are pregnant (negative pregnancy test required for all women of child-bearing potential at Visit 2, Day 0) or breast-feeding
- Women of childbearing potential (women who are not surgically sterile or postmenopausal defined as amenorrhea for >12 months) who are not using at least one method of contraception*
- New York Heart Association (NYHA) Class III or IV heart failure
- Last known hemoglobin <10 g/dL
- Index ACS event presumed due to uncontrolled hypertension
(*) Varies by region
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Dalcetrapib
Participants received dalcetrapib 600 mg (two 300 mg tablets) orally once daily. dalcetrapib: Cholesterol Ester Transfer Protein inhibitor, 300 mg tablets |
Cholesterol Ester Transfer Protein inhibitor
|
Placebo Comparator: Placebo
Participants received dalcetrapib placebo tablets matching dalcetrapib orally once daily. Placebo: dalcetrapib matching placebo tablets |
matching placebo tablets
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Composite of Cardiovascular Death, Resuscitated Cardiac Arrest, Non-Fatal Myocardial Infarction, and Non-Fatal Stroke
Time Frame: From randomization to the first occurrence of any component of the composite primary endpoint (median duration of follow-up was 39.9 months)
|
All efficacy endpoints were adjudicated by an independent clinical endpoint committee (CEC).
The primary efficacy endpoint was the time from randomization to the first occurrence of any component of the composite endpoint, which included death from cardiovascular causes, resuscitated cardiac arrest, non-fatal myocardial infarction, or non-fatal stroke, as positively adjudicated by the CEC.
|
From randomization to the first occurrence of any component of the composite primary endpoint (median duration of follow-up was 39.9 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Composite Endpoint of Cardiovascular Death, Resuscitated Cardiac Arrest, Non-Fatal Myocardial Infarction, Non-Fatal Stroke, Hospitalization for ACS (With Electrocardiogram Abnormalities) or Unanticipated Coronary Revascularization
Time Frame: From randomization to the first occurrence of any component of the composite secondary endpoint (median duration of follow-up was 39.9 months)
|
All efficacy endpoints were adjudicated by an independent clinical endpoint committee (CEC).
The primary efficacy endpoint was the time from randomization to the first occurrence of any component of the composite endpoint, which included death from cardiovascular causes, resuscitated cardiac arrest, non-fatal myocardial infarction, non-fatal stroke, hospitalization for acute coronary syndrome (with electrocardiogram abnormalities) or unanticipated coronary revascularization, as positively adjudicated by the CEC.
|
From randomization to the first occurrence of any component of the composite secondary endpoint (median duration of follow-up was 39.9 months)
|
Composite Endpoint of Cardiovascular Death, Resuscitated Cardiac Arrest, Non-Fatal Myocardial Infarction, Non-Fatal Stroke or Hospitalization for New or Worsening Heart Failure
Time Frame: From randomization to the first occurrence of any component of the composite secondary endpoint (median duration of follow-up was 39.9 months)
|
All efficacy endpoints were adjudicated by an independent clinical endpoint committee (CEC).
The secondary efficacy endpoint was the time from randomization to the first occurrence of any component of the composite secondary endpoint, which included death from cardiovascular causes, cardiovascular death, resuscitated cardiac arrest, non-fatal myocardial infarction, non-fatal stroke, or hospitalization for new or worsening heart failure, as positively adjudicated by the CEC.
|
From randomization to the first occurrence of any component of the composite secondary endpoint (median duration of follow-up was 39.9 months)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Donald M Black, MD, DalCor Pharmaceuticals
Publications and helpful links
General Publications
- Tardif JC, Pfeffer MA, Kouz S, Koenig W, Maggioni AP, McMurray JJV, Mooser V, Waters DD, Gregoire JC, L'Allier PL, Wouter Jukema J, White HD, Heinonen T, Black DM, Laghrissi-Thode F, Levesque S, Guertin MC, Dube MP; dal-GenE Investigators. Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial. Eur Heart J. 2022 Oct 14;43(39):3947-3956. doi: 10.1093/eurheartj/ehac374. Erratum In: Eur Heart J. 2022 Sep 20;:
- Black DM, Miller M, Heinonen TM, Zhang G. Advancing Beyond Failed High-density Lipoprotein Clinical Trials to Pharmacogenetic Studies of ADCY9 and Cholesterol Ester Transfer Protein Inhibition. J Cardiovasc Pharmacol. 2021 Oct 1;78(4):496-500. doi: 10.1097/FJC.0000000000001093. Review.
- Tardif JC, Dube MP, Pfeffer MA, Waters DD, Koenig W, Maggioni AP, McMurray JJV, Mooser V, White HD, Heinonen T, Black DM, Guertin MC; dal-GenE Investigators. Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib. Am Heart J. 2020 Apr;222:157-165. doi: 10.1016/j.ahj.2020.01.007. Epub 2020 Jan 17.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DAL-301
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Coronary Syndrome
-
Yonsei UniversityRecruitingCoronary Artery Disease, Acute Coronary SyndromeKorea, Republic of
-
Meditrix CorpNational University of Ireland, Galway, Ireland; Boston Scientific Japan K.K.; Fujita Health UniversityRecruitingChronic Coronary Syndrome | Non ST Segment Elevation Acute Coronary SyndromeJapan, Ireland
-
OrbusNeichDuke Clinical Research Institute; OrbusNeich Medical K.K.CompletedCoronary Arteriosclerosis | Non ST Segment Elevation Acute Coronary SyndromeUnited States, Japan
-
Medical University of WarsawRecruitingAcute Coronary Syndrome | Chronic Coronary Syndrome | Non ST Segment Elevation Acute Coronary SyndromePoland
-
Niguarda HospitalCompletedAcute Coronary Syndrome With ST Elevation on Electrocardiogram | Acute Coronary Syndrome Without ST Elevation on Electrocardiogram | Noncritical Coronary Artery Disease Coronary Stenosis Less Than 50 Per Cent | Aortic AneurysmsItaly
-
Sohag UniversityRecruitingLeft Main Coronary Artery Disease With Acute Coronary SyndromeEgypt
-
Eli Lilly and CompanyDaiichi Sankyo, Inc.CompletedCoronary Arteriosclerosis | Acute Coronary SyndromesUnited States
-
University of PatrasCompletedCoronary Artery Disease (CAD) | Acute Coronary Syndrome (ACS)Greece
-
The First Affiliated Hospital with Nanjing Medical...Unknown
-
Yonsei UniversityCompletedAcute Coronary Syndrome (ACS)Korea, Republic of
Clinical Trials on dalcetrapib
-
Hoffmann-La RocheCompletedCoronary Heart DiseaseGermany, United States
-
Hoffmann-La RocheCompletedCoronary Heart DiseaseSwitzerland, France, Germany, Netherlands, Austria, Italy, United Kingdom
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedCardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)China, United States, Spain, Netherlands, Canada, France, Mexico, Poland, Hungary, Australia, Denmark, United Kingdom, Czech Republic
-
Hoffmann-La RocheCompletedCoronary Heart DiseaseUnited States
-
Hoffmann-La RocheCompletedCoronary Heart DiseaseNetherlands, United States, United Kingdom, Czechia
-
Hoffmann-La RocheCompletedA Study of the Effect of RO4607381 on Atherosclerotic Plaque in Patients With Coronary Heart DiseaseCoronary Heart DiseaseUnited States, Canada
-
Hoffmann-La RocheCompletedCoronary Heart DiseaseBelgium, Germany, Israel, Poland, Spain, United Kingdom, China, Korea, Republic of, United States, France, Switzerland, Canada, Ireland, New Zealand, South Africa, Hungary, Netherlands, Australia, Puerto Rico, Sweden, Austria, Arg... and more
-
DalCor PharmaceuticalsThe Montreal Health Innovations Coordinating Center (MHICC)RecruitingAcute Coronary SyndromeUnited States, Canada, Puerto Rico
-
Hoffmann-La RocheCompletedHealthy VolunteerNew Zealand